2-O-digalloyl-1,3,4,6-tetra-O-beta-D-galloylglucose



Compound IDCDAMM02759
Common name2-O-digalloyl-1,3,4,6-tetra-O-beta-D-galloylglucose
IUPAC name[5-[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxybenzoyl]oxy-3,4,6-tris[(3,4,5-trihydroxybenzoyl)oxy]oxan-2-yl]methyl 3,4,5-trihydroxybenzoate
Molecular formulaC48H36O30

Experimental data

Retention time11.75
Adduct[M+2H]2+
Actual mz547.071
Theoretical mz547.072
Error1.42
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.3986

Identifiers and class information

Inchi keySTYWZBSDQCXNQL-YHNAUUMRSA-N
SmilesO=C(OC1=CC(=CC(O)=C1O)C(=O)OC2C(OC(=O)C3=CC(O)=C(O)C(O)=C3)OC(COC(=O)C4=CC(O)=C(O)C(O)=C4)C(OC(=O)C5=CC(O)=C(O)C(O)=C5)C2OC(=O)C6=CC(O)=C(O)C(O)=C6)C7=CC(O)=C(O)C(O)=C7
SuperclassPhenylpropanoids and polyketides
ClassTannins

Pharmacokinetic properties

Number of descriptor values(#stars)17
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)30
Number of reactive functional groups (#rtvFG)7
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)1092.79
Computed dipole moment(dipole)8.742
Total solvent accessible surface area (SASA)1343.91
Hydrophobic component of SASA (FOSA)55.506
Hydrophilic component of SASA (FISA)929.052
Pie component of the SASA (PISA)359.348
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2706.74
Number of hydrogen bond donors (donorHB)17
Number of hydrogen bond acceptors (accptHB)26.95
Free energy of solvation of dipole (dip^2/V)0.0282363
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0826827
Globularity descriptor (glob)0.69892
Predicted polarizability in cubic angstroms (QPpolrz)86.339
Predicted hexadecane/gas partition coefficient (QPlogPC16)37.103
Predicted octanol/gas partition coefficient (QPlogPoct)72.229
Predicted water/gas partition coefficient (QPlogPw)56.543
Predicted octanol/water partition coefficient (QPlogPo/w)-3.61
Predicted aqueous solubility (QPlogS)-4.127
Conformation-independent predicted aqueous solubility (CIQPlogS)-10.965
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-8.118
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)0
Predicted brain/blood partition coefficient (QPlogBB)-13.924
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0
Predicted skin permeability, log Kp (QPlogKp)-14.496
PM3 calculated ionization potential (IP(ev))9.207
PM3 calculated electron affinity (EA(eV))0.869
Number of likely metabolic reactions (#metab)17
Prediction of binding to human serum albumin (QPlogKhsa)-1.563
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)575.016
Number of nitrogen and oxygen atoms (#NandO)30
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
O43570CA12Carbonic anhydrase XIIT16987SEA
Q16790CA9Carbonic anhydrase IXT64567SEA
P00915CA1Carbonic anhydrase IT13201SEA
P00918CA2Carbonic anhydrase IIT20401SEA
Q9ULX7CA14Carbonic anhydrase XIVT31992SEA
P06746POLBDNA polymerase beta (by homology)T06958SEA
P05121SERPINE1Plasminogen activator inhibitor-1T15556SEA
P14151SELLLeukocyte adhesion molecule-1T60526SEA
Q9NUW8TDP1Tyrosyl-DNA phosphodiesterase 1T33492SEA
P52209PGD6-phosphogluconate dehydrogenaseT76497SEA
Q99417MYCBPMYCBP messenger RNAT37298SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16987DI0046Bacterial infection[ICD-11: 1A00-1C4Z]O43570CA12
T16987DI0372Seborrhoeic dermatitis[ICD-11: EA81]O43570CA12
T64567DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q16790CA9
T13201DI0166Glaucoma[ICD-11: 9C61]P00915CA1
T13201DI0372Seborrhoeic dermatitis[ICD-11: EA81]P00915CA1
T20401DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P00918CA2
T20401DI0137Essential hypertension[ICD-11: BA00]P00918CA2
T20401DI0166Glaucoma[ICD-11: 9C61]P00918CA2
T20401DI0175Heart failure[ICD-11: BD10-BD1Z]P00918CA2
T20401DI0214Insomnia[ICD-11: 7A00-7A0Z]P00918CA2
T20401DI0372Seborrhoeic dermatitis[ICD-11: EA81]P00918CA2
T31992DI0046Bacterial infection[ICD-11: 1A00-1C4Z]Q9ULX7CA14
T31992DI0204Inborn metabolism deficiency[ICD-11: 5C50-5C59]Q9ULX7CA14
T06958DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P06746POLB
T15556DI0037Asthma[ICD-11: CA23]P05121SERPINE1
T15556DI0405Thrombosis[ICD-11: DB61-GB90]P05121SERPINE1
T60526DI0037Asthma[ICD-11: CA23]P14151SELL
T60526DI0088Circulatory system disease[ICD-11: BE2Z]P14151SELL
T76497DI0337Pituitary gland disorder[ICD-11: 5A60-5A61]P52209PGD
T37298DI0235Liver cancer[ICD-11: 2C12]Q99417MYCBP

Copyright © 2025